Evidence map›Paper›PMID 26269432›Full record

ArticleOrganic & biomolecular chemistry2015

Design of CID-cleavable protein cross-linkers: identical mass modifications for simpler sequence analysis.

Wynne V Kandur, Athit Kao, Danielle Vellucci, Lan Huang, Scott D Rychnovsky

Abstract read
In one paragraph

Article in Organic & biomolecular chemistry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Nanobodies as allosteric modulators of Parkinson's disease-associated LRRK2.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  2. Article
  3. Article
  4. Article
  5. Tools for 3D Interactome Visualization.Journal of proteome research · 2019
    Article
  6. Article
  7. Novel Concepts of MS-Cleavable Cross-linkers for Improved Peptide Structure Analysis.Journal of the American Society for Mass Spectrometry · 2017
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Wynne V KandurDepartment of Chemistry, University of California, Irvine, CA 92697, USA. srychnov@uci.edu.
Athit Kao
Danielle Vellucci
Lan Huang
Scott D Rychnovsky
University of California, Irvine · USUniversity of California System · USIrvine Valley College · US

Funding

Biomedical Informatics Training ProgramT15LM007443 · NLM · UNIVERSITY OF CALIFORNIA-IRVINE · PI BALDI, PIERRE · 2002 to 2012
$9.3M
Proteomics of the Proteasome Interacting NetworksR01GM074830 · NIGMS · UNIVERSITY OF CALIFORNIA-IRVINE · PI HUANG, LAN · 2005 to 2022
$6.1M
In Vivo Interactome and Dynamics of Cullin-Ring LigasesR01GM106003 · NIGMS · UNIVERSITY OF CALIFORNIA-IRVINE · PI HUANG, LAN, RYCHNOVSKY, SCOTT D. · 2013 to 2016
$772k
Function and Regulation of the CSN in the NF-kB Activation PathwayR21CA161807 · NCI · UNIVERSITY OF CALIFORNIA-IRVINE · PI HUANG, LAN · 2012 to 2013
$358k
NCI NIH HHS R21 CA161807NCI NIH HHS R21CA161807NIGMS NIH HHS R01 GM074830NIGMS NIH HHS R01GM074830-06A1NIGMS NIH HHS R01 GM106003NLM NIH HHS 5T15LM007443-10NLM NIH HHS T15 LM007443
6 · The paper itself

Abstract

The cross-linking Mass Spectrometry (XL-MS) technique has enormous potential for studying the interactions between proteins, and it can provide detailed structural information about the interaction interfaces in large protein complexes. Such information has been difficult to obtain by conventional structural methods. One of the primary impediments to the wider use of the XL-MS technique is the extreme challenge in sequencing cross-linked peptides because of their complex fragmentation patterns in MS. A recent innovation is the development of MS-cleavable cross-linkers, which allows direct sequencing of component peptides for facile identification. Sulfoxides are an intriguing class of thermally-cleavable compounds that have been shown to fragment selectively during low-energy collisional induced dissociation (CID) analysis. Current CID-cleavable cross-linkers create fragmentation patterns in MS(2) of multiple peaks for each cross-linked peptide. Reducing the complexity of the fragmentation pattern in MS(2) facilitates subsequent MS(3) sequencing of the cross-linked peptides. The first authentic identical mass linker (IML) has now been designed, prepared, and evaluated. Multistage tandem mass spectrometry (MS(n)) analysis has demonstrated that the IML cross-linked peptides indeed yield one peak per peptide constituent in MS(2) as predicted, thus allowing effective and sensitive MS(3) analysis for unambiguous identification. Selective fragmentation for IML cross-linked peptides from the 19S proteasome complex was observed, providing a proof-of-concept demonstration for XL-MS studies on protein complexes.

Indexed as

Cross-Linking ReagentsHumansPeptide FragmentsProteinsProteolysisTandem Mass SpectrometryCross-Linking ReagentsPeptide FragmentsProteins

Identifiers

PMID26269432
PMCPMC4581996
OpenAlexW2167905313

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.